These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 11948031)
21. What is the clinical value of lung volumes? Ruppel GL Respir Care; 2012 Jan; 57(1):26-35; discussion 35-8. PubMed ID: 22222123 [TBL] [Abstract][Full Text] [Related]
22. A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD. Cazzola M; Rogliani P; Curradi G; Segreti A; Ciaprini C; Pezzuto G; Saltini C Pulm Pharmacol Ther; 2009 Dec; 22(6):522-5. PubMed ID: 19481169 [TBL] [Abstract][Full Text] [Related]
23. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease. Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD Clin Physiol Funct Imaging; 2012 Jan; 32(1):12-8. PubMed ID: 22152074 [TBL] [Abstract][Full Text] [Related]
25. Plethysmographic lung volumes in children with sighing dyspnea. Wong KS; Chiu CY; Huang YH; Huang LJ Pediatr Int; 2009 Jun; 51(3):405-8. PubMed ID: 19419494 [TBL] [Abstract][Full Text] [Related]
26. Effects of BMI on static lung volumes in patients with airway obstruction. O'Donnell DE; Deesomchok A; Lam YM; Guenette JA; Amornputtisathaporn N; Forkert L; Webb KA Chest; 2011 Aug; 140(2):461-468. PubMed ID: 21310838 [TBL] [Abstract][Full Text] [Related]
27. Lung hyperinflation and flow limitation in chronic airway obstruction. Pellegrino R; Brusasco V Eur Respir J; 1997 Mar; 10(3):543-9. PubMed ID: 9072982 [TBL] [Abstract][Full Text] [Related]
28. Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD. Tanabe N; Muro S; Oguma T; Sato S; Kiyokawa H; Takahashi T; Kudo M; Kinose D; Kubo T; Hoshino Y; Ogawa E; Hirai T; Mishima M COPD; 2012 Aug; 9(4):401-8. PubMed ID: 22509949 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma. Bussamra MH; Cukier A; Stelmach R; Rodrigues JC Chest; 2005 Feb; 127(2):530-5. PubMed ID: 15705992 [TBL] [Abstract][Full Text] [Related]
30. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Taube C; Holz O; Mücke M; Jörres RA; Magnussen H Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1810-5. PubMed ID: 11734428 [TBL] [Abstract][Full Text] [Related]
31. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness. Chen C; Jian W; Gao Y; Xie Y; Song Y; Zheng J Int J Chron Obstruct Pulmon Dis; 2016; 11():2519-2526. PubMed ID: 27785008 [TBL] [Abstract][Full Text] [Related]
32. Assessment of bronchodilator response through changes in lung volumes in chronic airflow obstruction. Figueroa-Casas JB; Diez AR; Rondelli MP; Figueroa-Casas MP; Figueroa-Casas JC Medicina (B Aires); 2003; 63(5):377-82. PubMed ID: 14628645 [TBL] [Abstract][Full Text] [Related]
33. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study. Beeh KM; Korn S; Beier J; Jadayel D; Henley M; D'Andrea P; Banerji D Respir Med; 2014 Apr; 108(4):584-92. PubMed ID: 24534204 [TBL] [Abstract][Full Text] [Related]
34. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD. Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715 [TBL] [Abstract][Full Text] [Related]
35. Determining the time to maximal bronchodilator response in asthmatic children. Stavreska V; Verheggen M; Oostryck J; Stick SM; Hall GL J Asthma; 2009 Feb; 46(1):25-9. PubMed ID: 19191133 [TBL] [Abstract][Full Text] [Related]
36. [The role of lung volume measurements by plethysmography in the follow-up of asthma in children]. Labbé G; Merlin E; Kauffman C; Fauquert JL; Héraud MC; Labbé A Rev Mal Respir; 2010; 27(1):42-8. PubMed ID: 20146951 [TBL] [Abstract][Full Text] [Related]
37. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. Lindberg A; Szalai Z; Pullerits T; Radeczky E Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063 [TBL] [Abstract][Full Text] [Related]
38. Different therapeutic responses in chronic obstructive pulmonary disease subgroups. Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD Int J Tuberc Lung Dis; 2011 Aug; 15(8):1104-10. PubMed ID: 21740676 [TBL] [Abstract][Full Text] [Related]
39. Assessment of bronchodilator responsiveness in infants with bronchiolitis. A comparison of the tidal and the raised volume rapid thoracoabdominal compression technique. Modl M; Eber E; Weinhandl E; Gruber W; Zach MS Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):763-8. PubMed ID: 10712319 [TBL] [Abstract][Full Text] [Related]
40. Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failure. Uren NG; Davies SW; Jordan SL; Lipkin DP Eur Heart J; 1993 Jun; 14(6):744-50. PubMed ID: 8325299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]